Thursday, July 10, 2025

TOPICS

Home Tags U.S. Securities and Exchange Commission

Tag: U.S. Securities and Exchange Commission

Better Markets applauds Supreme Court decision on liability of fraud

PROVIDENCE – Better Markets, a nonprofit advocating for the public’s interests in financial markets, applauded a new U.S. Supreme Court decision in the case...

Galvin announces ‘landmark settlement’ with coin offering issuer AirFox

PROVIDENCE – Mass. Secretary of the Commonwealth William F. Galvin has reached a “landmark settlement” with Boston-based initial coin offering issuer AirFox. AirFox agreed to...
JAY CLAYTON is chairman of the U.S. Securities and Exchange Commission, which recently proposed to overhaul its conflict of interest rules for brokers. / BLOOMBERG FILE PHOTO/ANDREW HARRER

Trump’s SEC proposes rewrite of Obama-era broker conflict rules

NEW YORK – The U.S. Securities and Exchange Commission on Wednesday proposed overhauling its conflict of interest rules for brokers, a move likely ensuring...
MASSACHUSETTS SECRETARY OF THE COMMONWEALTH William F. Galvin, a strong proponent of the U.S. Department of Labor’s fiduciary rule, which is designed to reduce conflicts of interest for brokers offering retirement service, says he is dismayed by U.S. Securities and Exchange Commissioner Michael Piwowar’s comments last week denouncing the new rule. /COURTESY MASSACHUSETTS SECRETARY OF STATE'S OFFICE

Galvin warns against Piwowar’s disapproval of DOL fiduciary rule

BOSTON – Secretary of the Commonwealth William F. Galvin is pushing back on remarks made by a U.S. Securities and Exchange commissioner. Galvin, a strong...
A CORPORATE TAX CUT for New Haven, Conn.-based Alexion Pharmaceuticals was approved by the R.I. Economic Development Corporation Monday Night for the company's Smithfield location. / COURTESY ALEXION PHARMACEUTICALS

Alexion raided by Brazilian police in sales investigation

BRASILIA, Brazil - Alexion Pharmaceuticals Inc.’s Sao Paulo offices were raided by Brazilian authorities Monday as part of an investigation into the drugmaker’s sales...
- Featured Event -

Latest News